NorthWest Biotherapeutics Inc (NWBO)

[Maverick0408]

One of these scenarios ought to explain their behavior and actions:

1) The UK approvals are not coming soon. Therefore no hiring activity to accelerate the ramp up on NWBO side.

2) UK approvals around end of summer/early fall.

a) But they expect sales in 2024 to be fairly modest and therefore don’t see a need to add more people in 2023 to prepare for that growth.

OR

b) Sales/distribution/marketing/business development is licensed to a big pharma in some sort of partnership agreement immediately post UK approval. And this new partner company may be preparing behind the scenes.

While I am hoping that 2b is the most logical explanation, my bet is on 2a now given the history of this management, positioning by their social media army lately, and how our share price has been declining!